People with rare diseases often have mental health challenges related to their health care. These vary by disease, but there are common issues that make it difficult for individuals and their families, including delays in getting diagnosed, not knowing what will happen in the future, having limited treatments, and facing financial difficulties.
View our Market Insights webinar that features a candid conversation with panelists from AMCP's Market Insights Roundtable on Optimizing the Management of Inherited Blood Disorders, Part 2 - a follow-up program to the 2022 Roundtable.
Wet age-related macular degeneration is a condition that can lead to significant vision loss. It is treated with regular injections, which often work well at preventing vision loss but are a burden to patients with the condition.
Health care leaders will need plans for handling new treatments for inherited blood disorders. This might mean changing benefits for treatments to make sure patients can get gene therapy.
The expanding use of continuous glucose monitoring (CGM) has been transformative in diabetes care, providing valuable real-time data and insights for diabetes management. CGM coverage in Type 2 diabetes (T2D) has increased, reaching a broader population of patients with diabetes who are recommended for CGM per clinical guidelines.
Explore actionable strategies to optimize oncology care with targeted therapies. This document offers health plan best practices, focusing on patient safety, equitable access, and evidence-based policies for effective cancer treatment. Discover innovative tools, multidisciplinary approaches, and transparent policies designed to improve patient and provider outcomes.